Two papers from the WOMAN Trials Collaborators, published in The Lancet today, reveal important evidence on the effects of the drug tranexamic acid (TXA) on postpartum haemorrhage (PPH) and life-threatening …
This article was written by the WOMAN Trials team. A year ago today, the WHO released its first roadmap to combat deaths from postpartum haemorrhage (PPH) – a condition …
“Some of the most disadvantaged women took part in the WOMAN-2 Trial. They shared their experiences with us so that we could learn from them. “This is why we’ve been …
In this film, LSHTM Professors Haleema Shakur-Still and Ian Roberts reflect on their late colleague Professor Bukola Fawole. While working on the WOMAN Trial, he presciently recognised the significance of …
Wider use of tranexamic acid (TXA) in surgery would improve surgical outcomes, avoid unnecessary blood transfusions and conserve blood stocks, according to an article published today in the British Medical …
On 20 May, Clinical Trials Day (ICTD), we celebrate the trailblazers among us who are making an impact through their research. Trailblazers are those who power the advancement of human …
Written by Professor Ian Roberts, Professor of Epidemiology at LSHTM and co-lead of the WOMAN-2 Trial. I read with interest Kasia Strek’s article in the Guardian this week, “Pregnancy is …
On 21 April, we mark the eight-year anniversary of the passing of Utako Okamoto, a Japanese medical doctor who discovered tranexamic acid in the 1950s in her quest to find …
A woman’s right to make informed decisions about her own health is critical. Empowering women with knowledge, and involving them in decision-making processes, are essential steps towards ensuring safer childbirth. …
Written by Professor Ian Roberts, Professor of Epidemiology at LSHTM and co-lead of the WOMAN-2 Trial. Access to quality health services is a basic human right. This is reflected in …